Search Results - "Buracchi, Chiara"

Refine Results
  1. 1

    Megakaryocytes Contribute to the Bone Marrow‐Matrix Environment by Expressing Fibronectin, Type IV Collagen, and Laminin by Malara, Alessandro, Currao, Manuela, Gruppi, Cristian, Celesti, Giuseppe, Viarengo, Gianluca, Buracchi, Chiara, Laghi, Luigi, Kaplan, David L., Balduini, Alessandra

    Published in Stem cells (Dayton, Ohio) (01-04-2014)
    “…Megakaryocytes associate with the bone marrow vasculature where they convert their cytoplasm into proplatelets that protrude through the vascular endothelium…”
    Get full text
    Journal Article
  2. 2

    Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment by Liguori, Manuela, Buracchi, Chiara, Pasqualini, Fabio, Bergomas, Francesca, Pesce, Samantha, Sironi, Marina, Grizzi, Fabio, Mantovani, Alberto, Belgiovine, Cristina, Allavena, Paola

    Published in Oncotarget (05-07-2016)
    “…Despite the accepted dogma that TRAIL kills only tumor cells and spares normal ones, we show in this study that mononuclear phagocytes are susceptible to…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Increased inflammation in mice deficient for the chemokine decoy receptor D6 by de la Torre, Yeny Martinez, Locati, Massimo, Buracchi, Chiara, Dupor, Jana, Cook, Donald N., Bonecchi, Raffaella, Nebuloni, Manuela, Rukavina, Daniel, Vago, Luca, Vecchi, Annunciata, Lira, Sergio A., Mantovani, Alberto

    Published in European journal of immunology (01-05-2005)
    “…Chemokines are chemotactic cytokines with a key role in the control of cell trafficking and positioning under homeostatic and inflammatory conditions. D6 is a…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The CCL3 Family of Chemokines and Innate Immunity Cooperate In Vivo in the Eradication of an Established Lymphoma Xenograft by Rituximab by Cittera, Elena, Leidi, Marzia, Buracchi, Chiara, Pasqualini, Fabio, Sozzani, Silvano, Vecchi, Annunciata, Waterfield, J. Douglas, Introna, Martino, Golay, Josee

    Published in Journal of Immunology (15-05-2007)
    “…The therapeutic mAb rituximab induced the expression of the CCL3 and CCL4 chemokines in the human lymphoma line BJAB following binding to the CD20 Ag…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Role of Microenvironment in Influencing the Activity of CD19 CAR T Cells in B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL) by Ponzo, Marianna, Drufuca, Lorenzo, Buracchi, Chiara, Nucera, Silvia, Bugarin, Cristina, Rossetti, Grazisa, Bonnal, Raoul, Rambaldi, Benedetta, Biondi, Andrea, Gaipa, Giuseppe, Pagani, Massimiliano, Magnani, Chiara Francesca

    Published in Blood (02-11-2023)
    “…Background: As a therapy based on immune cells, CAR T cells treatment elicits an acute response involving both innate and adaptive immunity which is followed…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges by Gaipa, Giuseppe, Buracchi, Chiara, Biondi, A

    Published in Expert review of molecular diagnostics (02-09-2018)
    “…Flow cytometric quantification of minimal residual disease (MRD) in acute leukemia (AL) represents an indispensable tool to guide modern therapeutic protocols…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Single‐cell profiling of pediatric T‐cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways by Bonaccorso, Paola, Bugarin, Cristina, Buracchi, Chiara, Fazio, Grazia, Biondi, Andrea, Lo Nigro, Luca, Gaipa, Giuseppe

    Published in Cytometry. Part B, Clinical cytometry (01-11-2020)
    “…Background The PI3K/Akt/mTOR (PI3K) signaling pathway has a crucial role in T‐cell acute lymphoblastic leukemias (T‐ALLs). Although loss‐of‐function of…”
    Get full text
    Journal Article